SCHEMBL7698793

SCHEMBL7698793

CCN1CCCC1CNC(=O)Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MCHR1 Q99705 2/20 0.47
MCHR2 Q969V1 1/20 0.47
KDR P35968 4/20 0.47
CHEK1 O14757 3/20 0.46
HCRTR1 O43613 1/20 0.44
HCRTR2 O43614 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
KCNH2 Q12809 1/20 0.43
THRB P10828 1/20 0.43
NAMPT P43490 1/20 0.43
CDK1 P06493 1/20 0.42
CDK2 P24941 1/20 0.42
OPRM1 P35372 2/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702887 0.80 HPGD (0.53) RAB9AKDRCHEK1ALDH1A1NAMPT
SCHEMBL7696947 0.79 KDR (0.47) KDRCHEK1CDK1CDK2OPRD1
SCHEMBL7701963 0.78 CHEK1 (0.57) KDRCHEK1KCNH2CDK1CDK2
SCHEMBL7704058 0.77 CHRM3 (0.54) CHEK1
SCHEMBL7698769 0.77 KDR (0.58) KDRCHEK1KCNH2NAMPTCDK1
SCHEMBL7696882 0.77 CHEK1 (0.51) MCHR1KDRCHEK1KCNH2NAMPT
Urea SCHEMBL7696206 0.76 MEN1 (0.52) KDRCHEK1KCNH2CDK1CDK2
SCHEMBL7701206 0.75 CHEK1 (0.49) KDRCHEK1KCNH2CDK1CDK2
SCHEMBL7000769 0.75 CHEK1 (0.64) RAB9AKDRCHEK1CDK1CDK2
SCHEMBL7698455 0.75 CHEK1 (0.56) RAB9ASMN1; SMN2KDRCHEK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed